Table 2.
Author | Publication Date | Study Location | Cohort Size | Study Design | Diagnostic Criteria | Relevant Exposure | Findings |
---|---|---|---|---|---|---|---|
Connolly et al. [31] | Aug-16 | Cincinnati Children’s Hospital Medical Center’s 2009–2014 | 503 | case control | ICD9 | pre pregnancy weight/BMI, GDM | Maternal obesity (BMI≥ 30) and GDM were associated with approximately 1.5-fold increased odds of having a child with an ASD. For mothers with both GDM and obesity, the association was twofold. |
Cordero et al. [80] | Jun-19 | The Study to Explore Early Development (SEED) is a U.S. multisite. California, Colorado, Georgia, Maryland, North Carolina, and Pennsylvania | 698 | case control | ADOS and ADI-R | pre pregnancy DM, GDM and HTN prior and during pregnancy | Hypertension (pre pregnancy and PIH/preeclampsia) was associated with ASD (aOR = 1.69 [95% CI 1.26, 2.26]). Diabetes (pre gestational an GDM clustered) during pregnancy was not associated with ASD (aOR = 1.10 [95% CI 0.77, 1.56]). |
Dodds et al. [81] | Jul-11 | 1990 and 2002 in Nova Scotia | 924 | cohort | ICD-9 or ICD-10 | pregnancy wt gain, pre pregnancy weight, pre pregnancy HTN, HTN during pregnancy | Univariate: Pregnancy weight gain ≥18 kg RR 1.26 (1.08–1.47), Pregnancy induced hypertension (PIH) RR 1.24 (1.02–1.52), pre pregnancy weight >90kg RR 1.72 (1.39–2.13), pre gestational DM RR1.98 (0.94–4.16), materal weight at delivery >120kg RR 2.18 (1.1–3.16), GDM RR 1.29 (0.9–1.83). Multivariate: Pre-pregnancy weight ≥90 kg RR 1.58 (1.26–1.98), Pregnancy weight gain ≥18 kg RR 1.19 (1.02–1.39), no other data. |
Getz et al. [82] | Sep-16 | General Practice Research Database from 1993 through 2008 (“about 6% of the population of England, Nortern Ireland, Scotland and Wales” | 889 | case control | E140.00 Infantile autism, *diagnostic source was not reported | maternal pre-pregnancy BMI | ORs for maternal obesity 1.54 [95% CI: 1.26, 1.89] |
Krakowiak et al. [83] | May-12 | CHARGE (Childhood Autism Risks from Genetics and the Environment) study in California, January 2003 and June 2010 | 517 | case control | ADOS and ADI-R | maternal T2D or GDM in the index pregnancy. Other conditions of interest were hypertension and obesity, defined as BMI >30 with onset before index pregnancy | The association between diabetes (T2DM or GDM) and ASD did not reach statistical significance, the association between hypertension (during pregnancy and before) and ASD was not signinficant. The risk of having a child with ASD to TD, was significantly increased among obese women (ASD, OR: 1.67 [95% CI: 1.10–2.56], |
Mann et al. [85] | May-10 | South Carolina, 1996 through 2002 | 472 | case control | ICD-9 | Pre-eclampsia/eclampsia | OR 1.69 (1.26–2.28) |
Shen et al. [86] | Jan-18 | Han Chinese population. | 705 | case control | DSM-IV-TR | maternal pre-pregnancy BMI, GWG | Excessive GWG was associated with autism risk (OR = 1.327, 95% CI: 1.021–1.725) Excessive GWG increased the risk of autism in overweight/obese mothers (OR = 2.468, 95% CI: 1.102–5.526) |
Surén et al. [87] | May-14 | Norwegian Mother and Child Cohort Study | 419 | case control | DSM-IV-TR | Maternal and paternal height and weight were recorded in a questionnaire completed by the mothers during week 18 of pregnancy | Maternal BMI <18.5: OR 1.39 (0.79–2.46) BMI 25.0–29.9 : 1.29 (0.99–1.69) BMI >30.0: 1.17 (0.81–1.7) |
Walker et al. [88] | Feb-15 | California January 29, 2003, through April 7, 2011, (CHARGE) study | 517 | case control | ADOS and ADI-R | Preeclampsia | OR 2.36; 95% CI, 1.18–4.68);” |
Windham et al. [89] | Feb-19 | Study to Explore Early Development (SEED), a multi-site case-control study of children born in 2003–2006. California, Colorado, Georgia, Maryland, North Carolina, and Pennsylvania | 540 | case control | ADOS and ADI-R | Maternal height, weight, and GWG were self-reported | BMI ≥25 & < 30 1.25 (0.94–1.68), BMI>30 OR 1.37 (0.98–1.92). GWG 35–44lb OR 1.52 (1.05–2.22) GWG >44lb OR = 1.58 (1.08–2.31) |
Xiang et al. [90] | Jun-19 | Kaiser Permanente Southern California (KPSC) hospitals between January 1, 2012, and December 31, 2013 | 707 | cohort | ICD-9 | HbA1c screening in the early prenatal period | HbA1c > 6.5% (n-15) HR 1.79 (1.06–3.00) |